| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and cash equivalents | $155.0M-0.3% | $155.4M+3.5% | $150.1M |
| Accounts receivable | $3.3M-84.6% | $21.2M+0.2% | $21.1M |
| Inventory | $49.1M-1.0% | $49.6M-22.8% | $64.2M |
| Prepaid expenses and other current assets | $5.6M+13.4% | $4.9M+40.6% | $3.5M |
| Total current assets | $212.9M-7.9% | $231.0M-3.3% | $239.0M |
| Property, plant and equipment, net | $1.1M-16.0% | $1.3M-2.5% | $1.3M |
| Deferred tax asset, net | $4.4M-59.2% | $10.9M-1.8% | $11.0M |
| Goodwill | $898K+0.0% | $898K+0.0% | $898K |
| Other assets | $193K-19.9% | $241K-88.4% | $2.1M |
| Total assets | $219.5M-10.2% | $244.3M-3.9% | $254.4M |
| Accounts payable | $825K-38.5% | $1.3M-8.0% | $1.5M |
| Accrued Liabilities, Current | $6.5M+15.6% | $5.6M-44.6% | $10.2M |
| Deferred IV TPOXX® revenue | $10.2M-0.9% | $10.3M-50.3% | $20.8M |
| Income tax payable | $408K-94.9% | $8.0M-63.0% | $21.7M |
| Total current liabilities | $18.0M-29.0% | $25.3M-53.2% | $54.1M |
| Other Liabilities, Noncurrent | $2.7M-17.1% | $3.2M | — |
| Total liabilities | $20.6M-27.6% | $28.5M-50.4% | $57.5M |
| Common stock ($.0001 par value, 600,000,000 shares authorized, 71,611,302 and 71,404,669 issued and outstanding at December 31, 2025 and December 31, 2024, respectively) | $7K+0.3% | $7K+0.4% | $7K |
| Additional paid-in capital | $241.9M+1.4% | $238.6M+1.2% | $235.8M |
| Accumulated deficit | -$43.1M-88.6% | -$22.8M+41.4% | -$38.9M |
| Total stockholders' equity | $198.8M-7.9% | $215.8M+9.6% | $196.9M |
| Total liabilities and stockholders' equity | $219.5M-10.2% | $244.3M-3.9% | $254.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.